Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-22-000282
Filing Date
2022-04-14
Accepted
2022-04-14 13:07:34
Documents
45
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sybleu033122form10q.htm   iXBRL 10-Q 571990
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8143
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 10097
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4785
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4810
  Complete submission text file 0001607062-22-000282.txt   2433436

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cik0001818674-20220331.xsd EX-101.SCH 19842
7 XBRL CALCULATION FILE cik0001818674-20220331_cal.xml EX-101.CAL 34203
8 XBRL DEFINITION FILE cik0001818674-20220331_def.xml EX-101.DEF 43829
9 XBRL LABEL FILE cik0001818674-20220331_lab.xml EX-101.LAB 147292
10 XBRL PRESENTATION FILE cik0001818674-20220331_pre.xml EX-101.PRE 120950
39 EXTRACTED XBRL INSTANCE DOCUMENT sybleu033122form10q_htm.xml XML 274415
Mailing Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001
Business Address 109 EAST 17TH STREET SUITE 460 CHEYENNE WY 82001 6192279192
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-248059 | Film No.: 22826672
SIC: 2834 Pharmaceutical Preparations